Top

Journal of Cardiovascular Magnetic Resonance

Published in:

Open Access 01-12-2012 | Review

CMR in inflammatory vasculitis

Authors: Subha V Raman, Ashish Aneja, Wael N Jarjour

Published in: Journal of Cardiovascular Magnetic Resonance | Issue 1/2012

Abstract

Vasculitis, the inflammation of blood vessels, can produce devastating complications such as blindness, renal failure, aortic rupture and heart failure through a variety of end-organ effects. Noninvasive imaging with cardiovascular magnetic resonance (CMR) has contributed to improved and earlier diagnosis. CMR may also be used in serial evaluation of such patients as a marker of treatment response and as an indicator of subsequent complications. Unique strengths of CMR favoring its use in such conditions are its abilities to noninvasively visualize both lumen and vessel wall with high resolution. This case-based review focuses on the large- and medium-vessel vasculitides where MR angiography has the greatest utility. Because of increasing recognition of cardiac involvement in small-vessel vasculitides, this review also presents evidence supporting greater consideration of CMR to detect and quantify myocardial microvascular disease. CMR’s complementary role amidst traditional clinical, serological and other diagnostic techniques in personalized care for patients with vasculitis is emphasized. Specifically, the CMR laboratory can address questions related to extent and severity of vascular involvement. As ongoing basic and translational studies better elucidate poorly-defined underlying molecular mechanisms, this review concludes with a discussion of potential directions for the development of more targeted imaging approaches.

Available only for authorised users

Scott DG, Watts RA: Systemic vasculitis: epidemiology, classification and environmental factors. Ann Rheum Dis. 2000, 59: 161-163. 10.1136/ard.59.3.161.PubMedCentralCrossRefPubMed

Gonzalez-Gay MA, Garcia-Porrua C: Epidemiology of the vasculitides. Rheum Dis Clin North Am. 2001, 27: 729-749. 10.1016/S0889-857X(05)70232-5.CrossRefPubMed

Jayne D: The diagnosis of vasculitis. Best Pract Res Clin Rheumatol. 2009, 23: 445-453. 10.1016/j.berh.2009.03.001.CrossRefPubMed

Pipitone N, Versari A, Salvarani C: Role of imaging studies in the diagnosis and follow-up of large-vessel vasculitis: an update. Rheumatology (Oxford). 2008, 47: 403-408.CrossRef

Luqmani RA, Pathare S, Kwok-Fai TL: How to diagnose and treat secondary forms of vasculitis. Best Pract Res Clin Rheumatol. 2005, 19: 321-336. 10.1016/j.berh.2004.11.002.CrossRefPubMed

Mavrogeni S, Vassilopoulos D: Is there a place for cardiovascular magnetic resonance imaging in the evaluation of cardiovascular involvement in rheumatic diseases?. Semin Arthritis Rheum. 2011, 41: 488-496. 10.1016/j.semarthrit.2011.04.004.CrossRefPubMed

Zuccoli G, Pipitone N, Haldipur A, Brown RD, Hunder G, Salvarani C: Imaging findings in primary central nervous system vasculitis. Clin Exp Rheumatol. 2011, 29: S104-S109.PubMed

Berlit P: Diagnosis and treatment of cerebral vasculitis. Ther Adv Neurol Disord. 2010, 3: 29-42. 10.1177/1756285609347123.PubMedCentralCrossRefPubMed

Hartung MP, Grist TM, Francois CJ: Magnetic resonance angiography: current status and future directions. J Cardiovasc Magn Reson. 2011, 13: 19-10.1186/1532-429X-13-19.PubMedCentralCrossRefPubMed

10.

Krishnam MS, Tomasian A, Malik S, Desphande V, Laub G, Ruehm SG: Image quality and diagnostic accuracy of unenhanced SSFP MR angiography compared with conventional contrast-enhanced MR angiography for the assessment of thoracic aortic diseases. Eur Radiol. 2009, 20: 1311-1320.PubMedCentralCrossRefPubMed

11.

3rd Winner MW, Raman SV, Chung YC, Simonetti OP, Mihai G, Cook SC: Post-interventional three-dimensional dark blood MRI in the adult with congenital heart disease. Int J Cardiol. 2012, 158 (2): 276-71.

12.

Hodnett PA, Koktzoglou I, Davarpanah AH, Scanlon TG, Collins JD, Sheehan JJ, Dunkle EE, Gupta N, Carr JC, Edelman RR: Evaluation of peripheral arterial disease with nonenhanced quiescent-interval single-shot MR angiography. Radiology. 2011, 260: 282-293. 10.1148/radiol.11101336.PubMedCentralCrossRefPubMed

13.

Langford CA: Vasculitis. J Allergy Clin Immunol. 2009, 125: S216-225.CrossRefPubMed

14.

Borchers AT, Gershwin ME: Giant cell arteritis: A review of classification, pathophysiology, geoepidemiology and treatment. Autoimmun Rev. 2012, 11: A544-554. 10.1016/j.autrev.2012.01.003.CrossRefPubMed

15.

Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY, Lie JT, et al: The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum. 1990, 33: 1122-1128.CrossRefPubMed

16.

Kale N, Eggenberger E: Diagnosis and management of giant cell arteritis: a review. Curr Opin Ophthalmol. 2010, 21: 417-422. 10.1097/ICU.0b013e32833eae8b.CrossRefPubMed

17.

Evans JM, O'Fallon WM, Hunder GG: Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis. A population-based study. Ann Intern Med. 1995, 122: 502-507.PubMed

18.

Nuenninghoff DM, Hunder GG, Christianson TJ, McClelland RL, Matteson EL: Mortality of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years. Arthritis Rheum. 2003, 48: 3532-3537. 10.1002/art.11480.CrossRefPubMed

19.

Bossert M, Prati C, Balblanc JC, Lohse A, Wendling D: Aortic involvement in giant cell arteritis: current data. Joint Bone Spine. 2010, 78: 246-251.CrossRefPubMed

20.

Martinez-Valle F, Solans-Laque R, Bosch-Gil J, Vilardell-Tarres M: Aortic involvement in giant cell arteritis. Autoimmun Rev. 2010, 9: 521-524. 10.1016/j.autrev.2010.02.014.CrossRefPubMed

21.

Koenigkam-Santos M, Sharma P, Kalb B, Oshinski JN, Weyand CM, Goronzy JJ, Martin DR: Magnetic resonance angiography in extracranial giant cell arteritis. J Clin Rheumatol. 2011, 17: 306-310.PubMedCentralCrossRefPubMed

22.

Assie C, Janvresse A, Plissonnier D, Levesque H, Marie I: Long-term follow-up of upper and lower extremity vasculitis related to giant cell arteritis: a series of 36 patients. Medicine (Baltimore). 2011, 90: 40-51. 10.1097/MD.0b013e318206af16.CrossRef

23.

Karassa FB, Matsagas MI, Schmidt WA, Ioannidis JP: Meta-analysis: test performance of ultrasonography for giant-cell arteritis. Ann Intern Med. 2005, 142: 359-369.CrossRefPubMed

24.

Basu N, Watts R, Bajema I, Baslund B, Bley T, Boers M, Brogan P, Calabrese L, Cid MC, Cohen-Tervaert JW, et al: EULAR points to consider in the development of classification and diagnostic criteria in systemic vasculitis. Ann Rheum Dis. 2010, 69 (10): 1744-1750. 10.1136/ard.2009.119032.CrossRefPubMed

25.

Bley TA, Wieben O, Uhl M, Thiel J, Schmidt D, Langer M: High-resolution MRI in giant cell arteritis: imaging of the wall of the superficial temporal artery. AJR Am J Roentgenol. 2005, 184: 283-287.CrossRefPubMed

26.

Bley TA, Weiben O, Uhl M, Vaith P, Schmidt D, Warnatz K, Langer M: Assessment of the cranial involvement pattern of giant cell arteritis with 3T magnetic resonance imaging. Arthritis Rheum. 2005, 52: 2470-2477. 10.1002/art.21226.CrossRefPubMed

27.

Walter MA, Melzer RA, Schindler C, Muller-Brand J, Tyndall A, Nitzsche EU: The value of [18F]FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease. Eur J Nucl Med Mol Imaging. 2005, 32: 674-681. 10.1007/s00259-004-1757-9.CrossRefPubMed

28.

Meller J, Strutz F, Siefker U, Scheel A, Sahlmann CO, Lehmann K, Conrad M, Vosshenrich R: Early diagnosis and follow-up of aortitis with [(18)F]FDG PET and MRI. Eur J Nucl Med Mol Imaging. 2003, 30: 730-736. 10.1007/s00259-003-1144-y.CrossRefPubMed

29.

Cyran CC, Sourbron S, Bochmann K, Habs M, Pfefferkorn T, Rominger A, Raya JG, Reiser MF, Dichgans M, Nikolaou K, et al: Quantification of supra-aortic arterial wall inflammation in patients with arteritis using high resolution dynamic contrast-enhanced magnetic resonance imaging: initial results in correlation to [18F]-FDG PET/CT. Invest Radiol. 2011, 46 (9): 594-599. 10.1097/RLI.0b013e31821c44ed.CrossRefPubMed

30.

Blockmans D, de Ceuninck L, Vanderschueren S, Knockaert D, Mortelmans L, Bobbaers H: Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients. Arthritis Rheum. 2006, 55: 131-137. 10.1002/art.21699.CrossRefPubMed

31.

Both M, Ahmadi-Simab K, Reuter M, Dourvos O, Fritzer E, Ullrich S, Gross WL, Heller M, Bahre M: MRI and FDG-PET in the assessment of inflammatory aortic arch syndrome in complicated courses of giant cell arteritis. Ann Rheum Dis. 2008, 67: 1030-1033.CrossRefPubMed

32.

Ozen S, Ruperto N, Dillon MJ, Bagga A, Barron K, Davin JC, Kawasaki T, Lindsley C, Petty RE, Prieur AM, et al: EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis. 2006, 65: 936-941.PubMedCentralCrossRefPubMed

33.

Arnaud L, Haroche J, Toledano D, Cacoub P, Mathian A, Costedoat-Chalumeau N, Le Thi Huong-Boutin D, Cluzel P, Gorochov G, Amoura Z: Cluster analysis of arterial involvement in Takayasu arteritis reveals symmetric extension of the lesions in paired arterial beds. Arthritis Rheum. 2011, 63: 1136-1140. 10.1002/art.30240.CrossRefPubMed

34.

Yamada I, Nakagawa T, Himeno Y, Kobayashi Y, Numano F, Shibuya H: Takayasu arteritis: diagnosis with breath-hold contrast-enhanced three-dimensional MR angiography. J Magn Reson Imaging. 2000, 11: 481-487. 10.1002/(SICI)1522-2586(200005)11:5<481::AID-JMRI3>3.0.CO;2-4.CrossRefPubMed

35.

Garg SK, Mohan S, Kumar S: Diagnostic value of 3D contrast-enhanced magnetic resonance angiography in Takayasu's arteritis--a comparative study with digital subtraction angiography. Eur Radiol. 2011, 21 (8): 1658-1666. 10.1007/s00330-011-2090-x.CrossRefPubMed

36.

Andrews J, Al-Nahhas A, Pennell DJ, Hossain MS, Davies KA, Haskard DO, Mason JC: Non-invasive imaging in the diagnosis and management of Takayasu's arteritis. Ann Rheum Dis. 2004, 63: 995-1000. 10.1136/ard.2003.015701.PubMedCentralCrossRefPubMed

37.

Li D, Lin J, Yan F: Detecting disease extent and activity of Takayasu arteritis using whole-body magnetic resonance angiography and vessel wall imaging as a 1-stop solution. J Comput Assist Tomogr. 2011, 35: 468-474. 10.1097/RCT.0b013e318222d698.CrossRefPubMed

38.

Desai MY, Stone JH, Foo TK, Hellmann DB, Lima JA, Bluemke DA: Delayed contrast-enhanced MRI of the aortic wall in Takayasu's arteritis: initial experience. AJR Am J Roentgenol. 2005, 184: 1427-1431.CrossRefPubMed

39.

Choe YH, Han BK, Koh EM, Kim DK, Do YS, Lee WR: Takayasu's arteritis: assessment of disease activity with contrast-enhanced MR imaging. AJR Am J Roentgenol. 2000, 175: 505-511.CrossRefPubMed

40.

Jiang L, Li D, Yan F, Dai X, Li Y, Ma L: Evaluation of Takayasu arteritis activity by delayed contrast-enhanced magnetic resonance imaging. Int J Cardiol. 2012, 155 (2): 262-267. 10.1016/j.ijcard.2010.10.002.CrossRefPubMed

41.

Tso E, Flamm SD, White RD, Schvartzman PR, Mascha E, Hoffman GS: Takayasu arteritis: utility and limitations of magnetic resonance imaging in diagnosis and treatment. Arthritis Rheum. 2002, 46: 1634-1642. 10.1002/art.10251.CrossRefPubMed

42.

Hoffman GS: Takayasu arteritis: lessons from the American National Institutes of Health experience. Int J Cardiol. 1996, 54 (Suppl): S99-102.CrossRefPubMed

43.

Liang KP, Chowdhary VR, Michet CJ, Miller DV, Sundt TM, Connolly HM, Crowson CS, Matteson EL, Warrington KJ: Noninfectious ascending aortitis: a case series of 64 patients. J Rheumatol. 2009, 36: 2290-2297. 10.3899/jrheum.090081.CrossRefPubMed

44.

Khosroshahi A, Stone JH: A clinical overview of IgG4-related systemic disease. Curr Opin Rheumatol. 2011, 23: 57-66. 10.1097/BOR.0b013e3283418057.CrossRefPubMed

45.

Miller DV, Maleszewski JJ: The pathology of large-vessel vasculitides. Clin Exp Rheumatol. 2011, 29: S92-98.PubMed

46.

Stone JR: Aortitis, periaortitis, and retroperitoneal fibrosis, as manifestations of IgG4-related systemic disease. Curr Opin Rheumatol. 2010, 23: 88-94.CrossRef

47.

Schmidt J, Sunesen K, Kornum JB, Duhaut P, Thomsen RW: Predictors for pathologically confirmed aortitis after resection of the ascending aorta: a 12-year Danish nationwide population-based cross-sectional study. Arthritis Res Ther. 2011, 13: R87-10.1186/ar3360.PubMedCentralCrossRefPubMed

48.

Rojo-Leyva F, Ratliff NB, 3rd Cosgrove DM, Hoffman GS: Study of 52 patients with idiopathic aortitis from a cohort of 1,204 surgical cases. Arthritis Rheum. 2000, 43: 901-907. 10.1002/1529-0131(200004)43:4<901::AID-ANR23>3.0.CO;2-U.CrossRefPubMed

49.

Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, Shulman ST, Bolger AF, Ferrieri P, Baltimore RS, et al: Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young. American Heart Association. Circulation. 2004, 110: 2747-2771.PubMed

50.

Kato H, Sugimura T, Akagi T, Sato N, Hashino K, Maeno Y, Kazue T, Eto G, Yamakawa R: Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation. 1996, 94: 1379-1385. 10.1161/01.CIR.94.6.1379.CrossRefPubMed

51.

Gordon JB, Kahn AM, Burns JC: When children with Kawasaki disease grow up: myocardial and vascular complications in adulthood. J Am Coll Cardiol. 2009, 54: 1911-1920. 10.1016/j.jacc.2009.04.102.PubMedCentralCrossRefPubMed

52.

Nakamura Y, Aso E, Yashiro M, Uehara R, Watanabe M, Oki I, Yanagawa H: Mortality among persons with a history of kawasaki disease in Japan: mortality among males with cardiac sequelae is significantly higher than that of the general population. Circ J. 2008, 72: 134-138. 10.1253/circj.72.134.CrossRefPubMed

53.

Margossian R, Lu M, Minich LL, Bradley TJ, Cohen MS, Li JS, Printz BF, Shirali GS, Sleeper LA, Newburger JW, Colan SD: Predictors of coronary artery visualization in Kawasaki disease. J Am Soc Echocardiogr. 2011, 24: 53-59. 10.1016/j.echo.2010.10.015.PubMedCentralCrossRefPubMed

54.

Greil GF, Seeger A, Miller S, Claussen CD, Hofbeck M, Botnar RM, Sieverding L: Coronary magnetic resonance angiography and vessel wall imaging in children with Kawasaki disease. Pediatr Radiol. 2007, 37: 666-673. 10.1007/s00247-007-0498-x.CrossRefPubMed

55.

Tacke CE, Kuipers IM, Groenink M, Spijkerboer AM, Kuijpers TW: Cardiac magnetic resonance imaging for noninvasive assessment of cardiovascular disease during the follow-up of patients with Kawasaki disease. Circ Cardiovasc Imaging. 2011, 4: 712-720. 10.1161/CIRCIMAGING.111.965996.CrossRefPubMed

56.

Greil GF, Stuber M, Botnar RM, Kissinger KV, Geva T, Newburger JW, Manning WJ, Powell AJ: Coronary magnetic resonance angiography in adolescents and young adults with kawasaki disease. Circulation. 2002, 105: 908-911. 10.1161/hc0802.105563.CrossRefPubMed

57.

Mavrogeni S, Papadopoulos G, Douskou M, Kaklis S, Seimenis I, Baras P, Nikolaidou P, Bakoula C, Karanasios E, Manginas A, Cokkinos DV: Magnetic resonance angiography is equivalent to X-ray coronary angiography for the evaluation of coronary arteries in Kawasaki disease. J Am Coll Cardiol. 2004, 43: 649-652. 10.1016/j.jacc.2003.08.052.CrossRefPubMed

58.

Suzuki A, Takemura A, Inaba R, Sonobe T, Tsuchiya K, Korenaga T: Magnetic resonance coronary angiography to evaluate coronary arterial lesions in patients with Kawasaki disease. Cardiol Young. 2006, 16: 563-571. 10.1017/S1047951106001168.CrossRefPubMed

59.

Arnold R, Ley S, Ley-Zaporozhan J, Eichhorn J, Schenk JP, Ulmer H, Kauczor HU: Visualization of coronary arteries in patients after childhood Kawasaki syndrome: value of multidetector CT and MR imaging in comparison to conventional coronary catheterization. Pediatr Radiol. 2007, 37: 998-1006. 10.1007/s00247-007-0566-2.CrossRefPubMed

60.

Han BK, Lindberg J, Overman D, Schwartz RS, Grant K, Lesser JR: Safety and accuracy of dual-source coronary computed tomography angiography in the pediatric population. J Cardiovasc Comput Tomogr. 2012, 6: 252-259. 10.1016/j.jcct.2012.01.004.CrossRefPubMed

61.

Mavrogeni S, Bratis K, Karanasios E, Georgakopoulos D, Kaklis S, Varlamis G, Kolovou G, Douskou M, Papadopoulos G: CMR evaluation of cardiac involvement during the convalescence of Kawasaki disease. JACC Cardiovasc Imaging. 2011, 4: 1140-1141. 10.1016/j.jcmg.2011.04.021.CrossRefPubMed

62.

Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, Shulman ST, Bolger AF, Ferrieri P, Baltimore RS, et al: Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young. American Heart Association. Pediatrics. 2004, 114: 1708-1733.PubMed

63.

Henegar C, Pagnoux C, Puechal X, Zucker JD, Bar-Hen A, Le Guern V, Saba M, Bagneres D, Meyer O, Guillevin L: A paradigm of diagnostic criteria for polyarteritis nodosa: analysis of a series of 949 patients with vasculitides. Arthritis Rheum. 2008, 58: 1528-1538. 10.1002/art.23470.CrossRefPubMed

64.

Mavrogeni S, Manoussakis MN, Karagiorga TC, Douskou M, Panagiotakos D, Bournia V, Cokkinos DV, Moutsopoulos HM: Detection of coronary artery lesions and myocardial necrosis by magnetic resonance in systemic necrotizing vasculitides. Arthritis Rheum. 2009, 61: 1121-1129. 10.1002/art.24695.CrossRefPubMed

65.

Kobayashi H, Yokoe I, Hattan N, Ohta H, Nakajima Y, Kobayashi Y: Cardiac magnetic resonance imaging in polyarteritis nodosa. J Rheumatol. 2010, 37: 2427-2429. 10.3899/jrheum.100450.CrossRefPubMed

66.

Zöller B, Li X, Sundquist J, Sundquist K: Risk of subsequent coronary heart disease in patients hospitalized for immune-mediated diseases: a nationwide follow-up study from Sweden. PLoS One. 2012, 7: e33442-10.1371/journal.pone.0033442.PubMedCentralCrossRefPubMed

67.

Sarica-Kucukoglu R, Akdag-Kose A, Kayabal IM, Yazganoglu KD, Disci R, Erzengin D, Azizlerli G: Vascular involvement in Behcet's disease: a retrospective analysis of 2319 cases. Int J Dermatol. 2006, 45: 919-921. 10.1111/j.1365-4632.2006.02832.x.CrossRefPubMed

68.

Calamia KT, Schirmer M, Melikoglu M: Major vessel involvement in Behcet's disease: an update. Curr Opin Rheumatol. 2011, 23: 24-31. 10.1097/BOR.0b013e3283410088.CrossRefPubMed

69.

Geri G, Wechsler B, Thi Huong Du L, Isnard R, Piette JC, Amoura Z, Resche-Rigon M, Cacoub P, Saadoun D: Spectrum of cardiac lesions in Behcet disease: a series of 52 patients and review of the literature. Medicine (Baltimore). 2012, 91: 25-34. 10.1097/MD.0b013e3182428f49.CrossRef

70.

Szczeklik W, Miszalski-Jamka T, Mastalerz L, Sokolowska B, Dropinski J, Banys R, Hor KN, Mazur W, Musial J: Multimodality assessment of cardiac involvement in Churg-Strauss syndrome patients in clinical remission. Circ J. 2011, 75: 649-655. 10.1253/circj.CJ-10-0772.CrossRefPubMed

71.

Vinit J, Bielefeld P, Muller G, Pfitzenmeyer P, Bonniaud P, Lorcerie B, Besancenot JF: Heart involvement in Churg-Strauss syndrome: retrospective study in French Burgundy population in past 10 years. Eur J Intern Med. 2010, 21: 341-346. 10.1016/j.ejim.2010.05.004.CrossRefPubMed

72.

Wassmuth R, Gobel U, Natusch A, Schneider W, Kettritz R, Dietz R, Luft FC, Schulz-Menger J: Cardiovascular magnetic resonance imaging detects cardiac involvement in Churg-Strauss syndrome. J Card Fail. 2008, 14: 856-860. 10.1016/j.cardfail.2008.07.227.CrossRefPubMed

73.

Chun W, Grist TM, Kamp TJ, Warner TF, Christian TF: Images in cardiovascular medicine, Infiltrative eosinophilic myocarditis diagnosed and localized by cardiac magnetic resonance imaging. Circulation. 2004, 110: e19-10.1161/01.CIR.0000135586.94417.3C.CrossRefPubMed

74.

Petersen SE, Kardos A, Neubauer S: Subendocardial and papillary muscle involvement in a patient with Churg-Strauss syndrome, detected by contrast enhanced cardiovascular magnetic resonance. Heart. 2005, 91: e9-10.1136/hrt.2004.050070.PubMedCentralCrossRefPubMed

75.

Su HS, Nahrendorf M, Panizzi PR, Breckwoldt MO, Rodriguez E, Iwamoto Y, Aikawa E, Weissleder R, Chen JW: Vasculitis: molecular imaging by targeting the inflammatory enzyme myeloperoxidase. Radiology. 2011, 262 (1): 181-90.CrossRefPubMed

Title: CMR in inflammatory vasculitis
Authors: Subha V Raman
Ashish Aneja
Wael N Jarjour
Publication date: 01-12-2012
Publisher: BioMed Central
Published in: Journal of Cardiovascular Magnetic Resonance / Issue 1/2012
Electronic ISSN: 1532-429X
DOI: https://doi.org/10.1186/1532-429X-14-82

Keynote webinar | Spotlight on medication adherence

Springer Medicine

CMR in inflammatory vasculitis

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2012

Semi-automatic segmentation of myocardium at risk in T2-weighted cardiovascular magnetic resonance

High-resolution intravascular magnetic resonance quantification of atherosclerotic plaque at 3T

Remodeling after acute myocardial infarction: mapping ventricular dilatation using three dimensional CMR image registration

Non-contrast T1-mapping detects acute myocardial edema with high diagnostic accuracy: a comparison to T2-weighted cardiovascular magnetic resonance

Infarct healing is a dynamic process following acute myocardial infarction

Pulmonary endarterectomy normalizes interventricular dyssynchrony and right ventricular systolic wall stress